FundedIQ
Biotechnology

Akoya Biosciences: Funding, Investors & Team (Sep 2026)

Akoya Biosciences' mission is to provide a deeper understanding of biology and human health by incorporating spatial phenotyping. They offer advanced imaging solutions that allow researchers to analyze individual cells in relation to their spatial context, gaining insight into disease progression and response to treatment. Akoya offers a range of products to cater to the needs of researchers in various stages of their work. To learn more about career opportunities at Akoya, visit their website. Additionally, you can stay updated with their latest news and content by following them on Twitter and subscribing to their YouTube channel.

www.akoyabio.com Marlborough, United States 251-500 employees
Total raised
$43.5M
Rounds
1
Latest
Undisclosed round
Jun 2023

Akoya Biosciences has raised $43.5M across 1 funding round on record, the most recent an undisclosed round of $43.5M announced in Jun 2023.

That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.

Akoya Biosciences Company Profile and Key Stats

Total funding raised
$43.5M
across 1 round on record
Funding rounds on record
1
Latest funding round
Undisclosed round
$43.5M in Jun 2023
Employees
251-500
reported band
Headquarters
Marlborough, United States

Latest funding round on record: Jun 2023.

Akoya Biosciences Funding Rounds

Date
Round
Amount
Undisclosed round
$43.5M

Akoya Biosciences Founders and Leadership Team

Name
Role
Contact
Garry Nolan
Founder

No contact details are on record for this team yet.

Akoya Biosciences Funding Compared to Other Biotechnology Startups

Segment
Companies
Median round
4,179
$8.0M
29,722
$7.5M

Akoya Biosciences' latest round of $43.5M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.

Funded Startups Like Akoya Biosciences in Biotechnology and Marlborough

Companies Similar to Akoya Biosciences

Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…

Convertible Note $6.8M

XiltriX North America is an information technology company that specializes in monitoring, predictive…

Undisclosed round $3.0M

Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…

Seed $3.1M

Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…

Series D $66.0M

Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…

Series B $92.7M

Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…

Series C $110M

InduPro is a biotechnology firm that focuses on protein therapeutics and technologies related to cell-surface…

Series B $77.0M

Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant…

Series A $6.3M

Legendary Bio's solidarity is a determined spotlight on introducing another period of quality guideline.

Series C $90.0M

Cataract surgery is the single most common procedure performed in the United States annually. Despite…

Series A $7.0M

InSitu Biologics is a developer of a drug delivery platform designed to focus on development of new and…

Convertible Note $1.3M

Remedium Bio is a gene therapy company in the Boston area that is dedicated to developing cures for severe…

Series A $10.0M

Akoya Biosciences Funding FAQs

What does Akoya Biosciences do?

Akoya Biosciences' mission is to provide a deeper understanding of biology and human health by incorporating spatial phenotyping. They offer advanced imaging solutions that allow researchers to analyze individual cells in relation to their spatial context, gaining insight into disease progression and response to treatment. Akoya offers a range of products to cater to the needs of researchers in various stages of their work. To learn more about career opportunities at Akoya, visit their website. Additionally, you can stay updated with their latest news and content by following them on Twitter and subscribing to their YouTube channel.

How much funding has Akoya Biosciences raised?

Akoya Biosciences has raised $43.5M across 1 round on record. The most recent is an undisclosed round of $43.5M announced in Jun 2023.

When did Akoya Biosciences last raise funding?

Akoya Biosciences' most recent funding round on record is an undisclosed round of $43.5M, announced in Jun 2023.

Who founded Akoya Biosciences?

FundedIQ lists Garry Nolan (Founder) at Akoya Biosciences.

Where is Akoya Biosciences headquartered?

Akoya Biosciences is based in Marlborough, Massachusetts, United States.

How many employees does Akoya Biosciences have?

Akoya Biosciences is in the 251-500 employee band.

How does Akoya Biosciences' funding compare to other Biotechnology startups?

Akoya Biosciences' latest round of $43.5M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.

About FundedIQ's Akoya Biosciences Funding Data

FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.

Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Akoya Biosciences is left off this page rather than filled in.

14-day free trial · Cancel anytime

Know who just raised. Then know who to reach.

Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.

Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.